Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma

Medical Science Monitor

Volumn 10, Issue 3, 2004, Pages

  Virág, László ^a   Bai, Péter ^b   Bak, István ^a   Pacher, Pál ^b   Mabley, Jon ^b   Liaudet, Lucas ^b   Bakondi, Edina ^a   Gergely, Pál ^a   Kollai, Márk ^c   Szabó, Csaba ^b,c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INOTEK CORPORATION   (United States)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Chemokine; Cytokine; Macrophage inflammatory protein; Poly(ADP ribose) polymerase; Tumor necrosis factor

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; EUKARYOTE; INFLAMMATORY CELL; MALE; MONONUCLEAR CELL; MOUSE; MULTINUCLEAR CELL; NONHUMAN; PATHOGENESIS;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE; CATALYSIS; CELL DEATH; CELL MOVEMENT; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENZYME INHIBITORS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-13; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; LUNG; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; PEROXIDASE; POLY(ADP-RIBOSE) POLYMERASES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12144291327     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. De Murcia G, Shall, S. (eds.): From DNA damage and stress signaling to cell death; poly ADP-ribosylation reactions. Oxford University Press, Oxford, England, 2000
2. Szabó C (ed.): Cell death: The role of PARP. CRC Press, Boca Raton, Florida, USA, 2000
3. Virag L, Szabó C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev, 2002; 54: 375-429
4. Zhang J, Dawson VL, Dawson TM, Snyder SH: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science, 1994; 263: 687-89
5. Szabó C, Zingarelli B, O'Connor M, Salzman AL: DNA strand breakage, activation of poly-ADP ribosyl synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA, 1996; 93: 1753-58
6. Virág L, Scott GS, Marmer D et al: Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology, 1998; 94: 345-55
7. Ha HC, Snyder SH: Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA, 1999; 96: 13978-82
8. Eliasson MJ, Sampei K, Mandir AS et al: Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med, 1997; 3: 1089-95
9. Zingarelli B, Salzman AL, Szabó C: Genetic disruption of poly (ADP ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia-reperfusion injury. Circ Res, 1998; 83: 85-94
10. Szabó C, Dawson VL: Role of poly (ADP-ribose) synthetase activation in inflammation and reperfusion injury. Trends Pharmacol Sci, 1998; 19: 287-98
11. Szabó C, Lim LH, Cuzzocrea S et al: Inhibition of poly (ADP-ribose) synthetase exerts anti-inflammatory effects and inhibits neutrophil recruitment. J Exp Med, 1997; 186: 1041-49
12. Cuzzocrea S, Zingarelli B, Gilad E et al: Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation. Eur J Pharm, 1998; 342: 67-76
13. Zingarelli B, Szabó C, Salzman AL: Blockade of Poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology, 1999; 116: 335-45
14. Szabó C, Virág L, Cuzzocrea S et al: Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly (ADP-ribose) synthetase. Proc Natl Acad Sci USA, 1998; 95: 3867-72
15. Oliver FJ, Menissier-de Murcia J, Nacci C et al: Resistance to endotoxic shock as a consequence of defective NF-kappa B activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J, 1999; 18: 4446-54
16. Hasko G, Mabley JG, Nemeth ZH et al: Poly(ADP-ribose) polymerase is a regulator of chemokine production: relevance for the pathogenesis of shock and inflammation. Mol Med, 2002; 8: 283-89
17. Mackay CR: Chemokines: immunology's high impact factors. Nat Immunol, 2001; 2: 95-101
18. De Sanctis GT, MacLean JA, Qin S et al: Interleukin-8 receptor modulates IgE production and B-cell expansion and trafficking in allergen-induced pulmonary inflammation. J Clin Invest, 1999; 103: 507-15
19. Mabley JG, Jagtap P, Perretti M et al: Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm Res, 2001; 50: 561-69
20. Soriano FG, Virag L, Jagtap P et al: Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 2001; 7: 108-13
21. Jagtap P, Soriano FG, Virag L et al: Novel phenanthridinone inhibitors of poly(adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med, 2002; 30: 1071-82
22. Menzies-Gow A, Robinson DS: Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma. Curr Opin Pulm Med, 2002; 8: 33-38
23. Blease K, Lukacs NW, Hogaboam CM, Kunkel SL: Chemokines and their role in airway hyper-reactivity. Respir Res, 2000; 1: 54-61
24. Rosenwasser LJ, Zimmermann N, Hershey GK et al: Chemokines in asthma: Cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol, 2003; 111: 227-42
25. Oshima T, Pavlick KP, Laroux FS et al: Regulation and distribution of MAdCAM-1 in endothelial cells in vitro. Am J Physiol Cell Physiol, 2001; 281: C1096-105
26. Veres B, Gallyas F Jr, Varbiro G et al: Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol, 2003; 65: 1373-82
27. Szabó E, Virag L, Bakondi E et al: Peroxynitrite production, DNA breakage, and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity. J Invest Dermatol 2001; 117: 74-80
28. Hassa PO, Hottiger MO: A role of poly (ADP-ribose) polymerase in NF-kappa B transcriptional activation. Biol Chem, 1999; 380: 953-58
29. Hassa PO, Covic M, Hasan S et al: The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J Biol Chem, 2001; 276: 45588-97
30. Chang WJ, Alvarez-Gonzalez R: The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1. J Biol Chem, 2001; 276: 47664-70
31. Ha HC, Hester LD, Snyder SH: Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci USA, 2002; 99: 3270-75
32. Southan GJ, Szabo C: Poly(ADP-Ribose) Polymerase inhibitors. Curr Med Chem, 2003; 10: 321-40
33. Boulares AH, Zoltoski AJ, Sherif ZA et al: Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. Am J Respir Cell Mol Biol, 2003; 28: 322-29